Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection

In HIV-1-infected patients, virological failure can occur as a consequence of the mutations that accumulate in the viral genome that allow replication to continue in the presence of antiretrovirals (ARVs). The development of treatment-emergent resistance to an ARV can limit a patient's options...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:AIDS Res Hum Retroviruses
Auteurs principaux: Boffito, Marta, Waters, Laura, Cahn, Pedro, Paredes, Roger, Koteff, Justin, Van Wyk, Jean, Vincent, Tia, Demarest, James, Adkison, Kimberly, Quercia, Romina
Format: Artigo
Langue:Inglês
Publié: Mary Ann Liebert, Inc., publishers 2020
Sujets:
Review Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944139/
https://ncbi.nlm.nih.gov/pubmed/31507204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2019.0171
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires